Good morning :)
$
R

Regencell Bioscience Holdings Ltd

RGC

NASDAQ
$5.912.12% (+0.12)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Drug Manufacturers - Specialty & Generic

Mid Cap

With a market cap of $2.9B the stock is ranked 1911

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2343.92
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.01
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

Company Profile

Peers

Peers

P/E Ratio
74.56
74.56
1Y Return
19.44%
19.44%
Buy Reco %
57.14
57.14
P/E Ratio
23.98
23.98
1Y Return
38.44%
38.44%
Buy Reco %
46.87
46.87
P/E Ratio
1Y Return
33.84%
33.84%
Buy Reco %
63.33
63.33
P/E Ratio
29.58
29.58
1Y Return
33.3%
33.3%
Buy Reco %
52.94
52.94
P/E Ratio
19.41
19.41
1Y Return
34.16%
34.16%
Buy Reco %
76.00
76.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - Specialty & Generic
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Regencell Bioscience Holdings Ltd -2343.92-
AbbVie Inc74.5650.450.54
Amgen Inc23.9817.832.32

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

-1.8
-1.7
-5.3
Q4 2024
Q3 2025
Q4 2025
Q1 2026
Revenue
Net Income
Financial YearQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q3 2025Q4 2025Q1 2026
Total Revenue----------
Net Income-2.64-0-0-0-0-0.92-1.85-1.73--5.31
Net Profit Margin----------

Frequently asked questions

  1. Regencell Bioscience Holdings Ltd (RGC) share price today is $5.91 as of September 22, 2026 at 1:30 AM IST. The stock touched a day high of $6.03 and a day low of $5.70.

  2. Regencell Bioscience Holdings Ltd stock trades on NASDAQ under the ticker symbol RGC.

  3. Regencell Bioscience Holdings Ltd's market capitalization is $2.86B as of September 22, 2026 at 1:30 AM IST.

  4. Regencell Bioscience Holdings Ltd's price-to-earnings (P/E) ratio is N/A as of September 21, 2026.

  5. Regencell Bioscience Holdings Ltd's price-to-book (P/B) ratio is 2343.92 as of September 21, 2026.

  6. Yes, You can buy Regencell Bioscience Holdings Ltd shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Regencell Bioscience Holdings Ltd shares in three steps: 1. Search Regencell Bioscience Holdings Ltd on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Regencell Bioscience Holdings Ltd trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Regencell Bioscience Holdings Ltd (RGC) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 1.6911 shares at the current price of $5.91.

Loading...